Clinical Trial Update: A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine [Phase 2]

View source ↗

Summary

Phase 2 trial update for dideoxyinosine (ddI) in HIV-infected children who failed or could not take zidovudine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dideoxyinosine (ddI)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED